← Back to Search

IMB Model-Based Intervention for HIV Prevention

N/A

Recruiting

Led By Steven A John, MPH, PhD

Research Sponsored by Medical College of Wisconsin

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

17-24 years old

Individuals who self-identify as male (including transgender men) and report any male sexual partners in the past 6 months

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial will test a new intervention to support HIV self-testing and pre-exposure prophylaxis uptake among young men who have sex with men. The intervention will be based on the Information-Motivation-Behavioral Skills model, and will include videos, directories, and other resources. The primary outcome will be HIVST and PrEP uptake, and secondary outcomes will include changes in IMB model indicators.

Who is the study for?

This trial is for young men (17-24 years old) who have sex with men, live in the US, and are at risk for HIV based on CDC criteria but not currently using PrEP. They should be HIV-negative or unsure of their status. Those with serious psychiatric symptoms, suicidal/homicidal tendencies, cognitive impairments, or current PrEP users cannot join.Check my eligibility

What is being tested?

The study tests an intervention based on the Information-Motivation-Behavioral Skills model to encourage HIV self-testing and pre-exposure prophylaxis (PrEP) uptake among participants. It's a randomized controlled trial that includes educational videos and resources about HIV testing and PrEP.See study design

What are the potential side effects?

Since this trial focuses on education and behavior change rather than medication, there are no direct side effects from drugs being tested. However, participants may experience emotional or psychological responses to the content.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 17 and 24 years old.

Select...

I am a man who has had male sexual partners in the last 6 months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in the number of self-reported HIV self-tests

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: IMBExperimental Treatment1 Intervention

Individuals randomized to this arm will receive a behavioral intervention based on the Information-Motivation-Behavior (IMB) model designed to increase HIV self-testing, among other protective behaviors.

Group II: No InterventionActive Control1 Intervention

Individuals randomized to this arm will receive no intervention.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Medical College of WisconsinLead Sponsor

609 Previous Clinical Trials

1,162,451 Total Patients Enrolled

Steven A John, MPH, PhDPrincipal InvestigatorMedical College of Wisconsin

Media Library

IMB Clinical Trial Eligibility Overview. Trial Name: NCT04865341 — N/A

HIV/AIDS Research Study Groups: IMB, No Intervention

HIV/AIDS Clinical Trial 2023: IMB Highlights & Side Effects. Trial Name: NCT04865341 — N/A

IMB 2023 Treatment Timeline for Medical Study. Trial Name: NCT04865341 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

May I be eligible to partake in this clinical trial?

"This clinical trial targets 132 individuals aged 17 to 24 who may identify as male, including those in the transgender community. To qualify, participants must be based in America and fall into one of the following categories: HIV-negative or unknown status; bacterial STI diagnosis; engaging in condomless anal sex (CAS) with a casual male partner; CAS with an HIV-positive or unknown status main partner; CAS with an HIV-negative main partner who reports CAS with other men."

Answered by AI

Are individuals over the age of 30 eligible to participate in this trial?

"This medical trial calls for participants between 17 and 24 years old. Conversely, there are 149 trials available to those under 18 while 466 exist for the elderly population above 65."

Answered by AI

Is enrollment open at the present time for this exploration?

"Contrary to expectation, clinicaltrials.gov reports that this trial is no longer seeking participants; the initial posting was made on January 1st 2023 and it's latest update occurred April 29th 2022. Nonetheless, there are 636 other medical studies currently actively recruiting patients."

Answered by AI

Recent research and studies

Archives of Sexual BehaviorJournal

Perceptions of Prep Use Within Primary Relationships Among Young Black Gay, Bisexual, and Other Men Who Have Sex with Men

Quinn, Katherine G., Meagan Zarwell, Steven A. John, Erika Christenson, and Jennifer L. Walsh. 2020. “Perceptions of Prep Use Within Primary Relationships Among Young Black Gay, Bisexual, and Other Men Who Have Sex with Men”. Archives of Sexual Behavior. Springer Science and Business Media LLC. doi:10.1007/s10508-020-01683-1.

Archives of Sexual BehaviorJournal

Willingness to Distribute HIV Self-testing Kits to Recent Sex Partners Among Hiv-negative Gay and Bisexual Men and an Examination of Free-response Data from Young Men Participating in the Nationwide Cohort

John, Steven A., Javier López-Rios, Tyrel J. Starks, H. Jonathon Rendina, and Christian Grov. 2020. “Willingness to Distribute HIV Self-testing Kits to Recent Sex Partners Among Hiv-negative Gay and Bisexual Men and an Examination of Free-response Data from Young Men Participating in the Nationwide Cohort”. Archives of Sexual Behavior. Springer Science and Business Media LLC. doi:10.1007/s10508-020-01752-5.

AIDS and BehaviorJournal

HIV Post-exposure Prophylaxis (PEP) Awareness and Non-occupational PEP (npep) Prescribing History Among U.S. Healthcare Providers

John, Steven A., Katherine G. Quinn, Benedikt Pleuhs, Jennifer L. Walsh, and Andrew E. Petroll. 2020. “HIV Post-exposure Prophylaxis (PEP) Awareness and Non-occupational PEP (npep) Prescribing History Among U.S. Healthcare Providers”. AIDS and Behavior. Springer Science and Business Media LLC. doi:10.1007/s10461-020-02866-6.

Plos OneJournal